Allogene Therapeutics Statistics
Total Valuation
ALLO has a market cap or net worth of $569.84 million. The enterprise value is $110.85 million.
| Market Cap | 569.84M |
| Enterprise Value | 110.85M |
Important Dates
The next estimated earnings date is Wednesday, May 1, 2024, after market close.
| Earnings Date | May 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ALLO has 169.09 million shares outstanding. The number of shares has increased by 9.63% in one year.
| Shares Outstanding | 169.09M |
| Shares Change (YoY) | +9.63% |
| Shares Change (QoQ) | +0.49% |
| Owned by Insiders (%) | 22.44% |
| Owned by Institutions (%) | 73.66% |
| Float | 111.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5,998.32 |
| Forward PS | 13,780.63 |
| PB Ratio | 1.11 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1,166.85 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.38, with zero debt.
| Current Ratio | 12.38 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -56.70% and return on invested capital (ROIC) is -63.98%.
| Return on Equity (ROE) | -56.70% |
| Return on Assets (ROA) | -45.60% |
| Return on Capital (ROIC) | -63.98% |
| Revenue Per Employee | $409 |
| Profits Per Employee | -$1.41M |
| Employee Count | 232 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -37.24% in the last 52 weeks. The beta is 0.80, so ALLO's price volatility has been lower than the market average.
| Beta (1Y) | 0.80 |
| 52-Week Price Change | -37.24% |
| 50-Day Moving Average | 4.44 |
| 200-Day Moving Average | 3.77 |
| Relative Strength Index (RSI) | 27.97 |
| Average Volume (30 Days) | 2,278,409 |
Short Selling Information
The latest short interest is 30.62 million, so 18.11% of the outstanding shares have been sold short.
| Short Interest | 30.62M |
| Short Previous Month | 27.75M |
| Short % of Shares Out | 18.11% |
| Short % of Float | 27.59% |
| Short Ratio (days to cover) | 11.76 |
Income Statement
In the last 12 months, ALLO had revenue of $95,000 and -$327.27 million in losses. Loss per share was -$2.09.
| Revenue | 95,000 |
| Gross Profit | 95,000 |
| Operating Income | -327.74M |
| Pretax Income | -327.27M |
| Net Income | -327.27M |
| EBITDA | -313.07M |
| EBIT | -327.27M |
| Loss Per Share | -$2.09 |
Balance Sheet
The company has $458.99 million in cash and no debt, giving a net cash position of $458.99 million or $2.71 per share.
| Cash & Cash Equivalents | 458.99M |
| Total Debt | n/a |
| Net Cash | 458.99M |
| Net Cash Per Share | $2.71 |
| Equity / Book Value | 512.23M |
| Book Value Per Share | 3.03 |
| Working Capital | 422.04M |
Cash Flow
In the last 12 months, operating cash flow was -$237.73 million and capital expenditures -$1.52 million, giving a free cash flow of -$239.25 million.
| Operating Cash Flow | -237.73M |
| Capital Expenditures | -1.52M |
| Free Cash Flow | -239.25M |
| FCF Per Share | -$1.53 |
Margins
Gross margin is 100.00%, with operating and profit margins of -344,986.32% and -344,489.47%.
| Gross Margin | 100.00% |
| Operating Margin | -344,986.32% |
| Pretax Margin | -344,489.47% |
| Profit Margin | -344,489.47% |
| EBITDA Margin | -329,543.16% |
| EBIT Margin | -344,489.47% |
| FCF Margin | -251,841.05% |
Dividends & Yields
ALLO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.63% |
| Shareholder Yield | -9.63% |
| Earnings Yield | -57.43% |
| FCF Yield | -41.99% |
Analyst Forecast
The average price target for ALLO is $15.39, which is 356.68% higher than the current price. The consensus rating is "Buy".
| Price Target | $15.39 |
| Price Target Difference | 356.68% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 493.59% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ALLO has an Altman Z-Score of -1.68 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.68 |
| Piotroski F-Score | 2 |